Sinopharm Group Co (1099) Stock Forecast & Price Target

Compare

8 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1099 Analyst Ratings

Moderate Sell

0 Buy

0 Hold

1 Sell

Based on 1 analysts giving stock ratings to

Sinopharm

Group Co

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1099 Stock 12 Month Forecast

Average Price Target

HK$19.50

▼(-3.85% Downside)

Based on 1 Wall Street analysts offering 12 month price targets for Sinopharm Group Co in the last 3 months. The average price target is HK$19.50 with a high forecast of HK$19.50 and a low forecast of HK$19.50. The average price target represents a -3.85% change from the last price of HK$20.28.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"HK$16","17":"HK$17","18":"HK$18","19":"HK$19","20":"HK$20"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":19.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$19.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$19.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$19.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,17,18,19,20],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.37,19.380000000000003,19.39,19.400000000000002,19.41,19.42,19.43,19.44,19.45,19.46,19.47,19.48,19.49,{"y":19.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.37,19.380000000000003,19.39,19.400000000000002,19.41,19.42,19.43,19.44,19.45,19.46,19.47,19.48,19.49,{"y":19.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.37,19.380000000000003,19.39,19.400000000000002,19.41,19.42,19.43,19.44,19.45,19.46,19.47,19.48,19.49,{"y":19.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.614,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.999,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.759,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.326,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.826,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.595,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.634,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.884,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.38,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.84,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.75,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.34,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.37,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetHK$19.50

Average Price TargetHK$19.50

Lowest Price TargetHK$19.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

HSBC

Not Ranked

HSBC

HK$18→HK$19.5

Sell

-3.85%

Downside

Reiterated

11/10/25

HSBC Keeps Their Sell Rating on Sinopharm Group Co (SHTDF)

Unknown Analyst

UBS

Not Ranked

UBS

HK$24.2

Buy

19.33%

Upside

Reiterated

10/27/25

Unknown Analyst

Daiwa

Not Ranked

Daiwa

HK$21

Buy

3.55%

Upside

Reiterated

10/27/25

Unknown Analyst

First Shanghai Securities

Not Ranked

First Shanghai Securities

HK$21.3

Buy

5.03%

Upside

Reiterated

09/26/25

Unknown Analyst

CICC

Not Ranked

CICC

HK$24.7

Buy

21.79%

Upside

Reiterated

08/27/25

Unknown Analyst

China Renaissance

Not Ranked

China Renaissance

HK$23.6

Buy

16.37%

Upside

Reiterated

08/26/25

Unknown Analyst

UOB Kay Hian

Not Ranked

UOB Kay Hian

HK$17.3

Sell

-14.69%

Downside

Reiterated

08/26/25

Unknown Analyst

Citi

Not Ranked

Citi

HK$22.7

Buy

11.93%

Upside

Reiterated

08/26/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$23

Buy

13.41%

Upside

Reiterated

08/25/25

Laurence Tam

Morgan Stanley

HK$22.5

Buy

10.95%

Upside

Reiterated

08/22/25

Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$22

Buy

8.48%

Upside

Reiterated

06/16/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$22.54

Buy

11.14%

Upside

Reiterated

04/02/25

Jialin Zhang

Nomura

HK$25.09→HK$23.4

Buy

15.38%

Upside

Reiterated

03/25/25

Sinopharm Group Co Ltd. (1099:HK) (SHTDF) PT Lowered to HK$23.40 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang lowered the price target on Sinopharm Group Co Ltd. (1099:HK) (OTC: SHTDF) to HK$23.40 (from HK$25.09) while maintaining a Buy rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

HSBC

Not Ranked

HSBC

HK$18→HK$19.5

Sell

-3.85%

Downside

Reiterated

11/10/25

HSBC Keeps Their Sell Rating on Sinopharm Group Co (SHTDF)

Unknown Analyst

UBS

Not Ranked

UBS

HK$24.2

Buy

19.33%

Upside

Reiterated

10/27/25

Unknown Analyst

Daiwa

Not Ranked

Daiwa

HK$21

Buy

3.55%

Upside

Reiterated

10/27/25

Unknown Analyst

First Shanghai Securities

Not Ranked

First Shanghai Securities

HK$21.3

Buy

5.03%

Upside

Reiterated

09/26/25

Unknown Analyst

CICC

Not Ranked

CICC

HK$24.7

Buy

21.79%

Upside

Reiterated

08/27/25

Unknown Analyst

China Renaissance

Not Ranked

China Renaissance

HK$23.6

Buy

16.37%

Upside

Reiterated

08/26/25

Unknown Analyst

UOB Kay Hian

Not Ranked

UOB Kay Hian

HK$17.3

Sell

-14.69%

Downside

Reiterated

08/26/25

Unknown Analyst

Citi

Not Ranked

Citi

HK$22.7

Buy

11.93%

Upside

Reiterated

08/26/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$23

Buy

13.41%

Upside

Reiterated

08/25/25

Laurence Tam

Morgan Stanley

HK$22.5

Buy

10.95%

Upside

Reiterated

08/22/25

Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$22

Buy

8.48%

Upside

Reiterated

06/16/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$22.54

Buy

11.14%

Upside

Reiterated

04/02/25

Jialin Zhang

Nomura

HK$25.09→HK$23.4

Buy

15.38%

Upside

Reiterated

03/25/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sinopharm Group Co

3 Months

xxx

Success Rate

4/4 ratings generated profit

Average Return

+10.95%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +10.95% per trade.

1 Year

Laurence TamMorgan Stanley

Success Rate

3/4 ratings generated profit

Average Return

+5.15%

reiterated a buy rating 5 months ago

Copying Laurence Tam's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +5.15% per trade.

2 Years

xxx

Success Rate

4/4 ratings generated profit

Average Return

+12.70%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +12.70% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1099 Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1099 has received 17 Buy Ratings, 31 Hold Ratings, and 2 Sell Ratings. 1099 average Analyst price target in the past 3 months is 19.50.

Each month's total comprises the sum of three months' worth of ratings.

1099 Financial Forecast

1099 Earnings Forecast

Next quarter’s earnings estimate for 1099 is HK$1.28 with a range of HK$1.28 to HK$1.28. The previous quarter’s EPS was HK$0.66. 1099 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year 1099 has Performed in-line its overall industry.

1099 Sales Forecast

Next quarter’s sales forecast for 1099 is HK$318.09B with a range of HK$318.09B to HK$318.09B. The previous quarter’s sales results were ―. 1099 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year 1099 has Performed in-line its overall industry.

1099 Stock Forecast FAQ

What is HK:1099’s average 12-month price target, according to analysts?

Based on analyst ratings, Sinopharm Group Co Ltd Class H’s 12-month average price target is 19.50.

What is HK:1099’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for HK:1099, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HK:1099 a Buy, Sell or Hold?

Sinopharm Group Co Ltd Class H has a consensus rating of Moderate Sell which is based on 0 buy ratings, 0 hold ratings and 1 sell ratings.

What is Sinopharm Group Co Ltd Class H’s price target?

The average price target for Sinopharm Group Co Ltd Class H is 19.50. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is HK$19.50 ,the lowest forecast is HK$19.50. The average price target represents -3.85% Decrease from the current price of HK$20.28.

What do analysts say about Sinopharm Group Co Ltd Class H?

Sinopharm Group Co Ltd Class H’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 1 Wall Streets Analysts.

How can I buy shares of HK:1099?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Sinopharm Group Co (1099) Stock Forecast & Price Target

1099 Analyst Ratings

1099 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Sinopharm Group Co

1099 Analyst Recommendation Trends

1099 Financial Forecast

1099 Earnings Forecast

1099 Sales Forecast

1099 Stock Forecast FAQ

Detailed List of Analyst Forecasts